Rockwell Medical Inc (RMTI)

NASD · Healthcare · Drug Manufacturers - Specialty & Generic · USA

Rockwell Medical Inc is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.

Rockwell Medical produces and supplies hemodialysis concentrates and ancillary products to dialysis providers worldwide. Its portfolio includes acid and bicarbonate concentrates in liquid and dry forms, along with mixers and cartridges used to treat end-stage kidney disease patients. The company serves dialysis clinics, hospitals, and other healthcare facilities in the United States and internationally.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Rockwell Medical Inc stock.

Our verdict on RMTI

Overvalued: intrinsic value $4.46 per share, market price $6.61, margin of safety -48.1% (as of 2026-11-17).

Its liquidation floor, current assets minus every liability, values the shares at $4.46; the price of $6.61 is 48% above that value.

ETFs with the most weight in RMTI

More on RMTI

Browse

Peers in Drug Manufacturers - Specialty & Generic

All 82 Drug Manufacturers - Specialty & Generic stocks

Cheaper than RMTI in Drug Manufacturers - Specialty & Generic

17 more in this industry show a wider margin of safety.

Is RMTI undervalued or overvalued?

RMTI is overvalued (as of the 2026-11-17 close). Its liquidation floor, current assets minus every liability, values the shares at $4.46; the price of $6.61 is 48% above that value.

What is the intrinsic value of RMTI?

$4.46 per share (as of the 2026-11-17 close), against a market price of $6.61. That is a margin of safety of -48.1%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.